Neurology

The CGTLive Neurology specialty topic page houses video interviews with key opinion leaders in the field of neurology about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings related to cell therapies, gene therapies, and engineered and regenerative medicines developed for neurologic disorders and diseases. It also contains up-to-date clinical news coverage in the field of gene and cell therapy for central nervous system disorders.

Latest News

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – October 4, 2024

October 4th 2024

Review top news and interview highlights from the week ending October 4, 2024.

Data Roundup: September 2024 Features Updates in Ophthalmology Gene Therapy, CAR-T for Lymphoma, and More
Data Roundup: September 2024 Features Updates in Ophthalmology Gene Therapy, CAR-T for Lymphoma, and More

October 4th 2024

Daniel Hart, PhD, the senior director and head of technology development at Epic Bio
CRISPR-Mediated In Vivo Epigenomic Activation

October 3rd 2024

Around the Helix: Cell and Gene Therapy Company Updates – October 2, 2024
Around the Helix: Cell and Gene Therapy Company Updates – October 2, 2024

October 2nd 2024

Myrtelle’s Canavan Disease Gene Therapy rAAV-Olig001-ASPA Decreases N-Acetylaspartate Levels in Phase 1/2 Study
Myrtelle’s Canavan Disease Gene Therapy rAAV-Olig001-ASPA Decreases N-Acetylaspartate Levels in Phase 1/2 Study

October 2nd 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.